CL4 MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF THE EFFICACY AND TOLERABILITY OF APALUTAMIDE AND DAROLUTAMIDE FOR THE TREATMENT OF NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC)

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.056
https://www.valueinhealthjournal.com/article/S1098-3015(19)32434-9/fulltext
Title : CL4 MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF THE EFFICACY AND TOLERABILITY OF APALUTAMIDE AND DAROLUTAMIDE FOR THE TREATMENT OF NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32434-9&doi=10.1016/j.jval.2019.09.056
First page :
Section Title :
Open access? : No
Section Order : 10017
Categories :
Tags :
Regions :
ViH Article Tags :